Bio-Oil: The Next-Generation Source of Chemicals
Reactions · 28.01.2022 · 3 (1) · 118-137
DOI: 10.3390/reactions3010009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reactions, online erschienen am 28.01.2022. Verfasst von Henrique Machado und 3 weiteren Autor:innen. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bio-oil, although rich in chemical species, is primarily used as fuel oil, due to its greater calorific power when compared to the biomass from which it is made. The incomplete understanding of how to explore its chemical potential as a source of value-added chemicals and, therefore, a supply of intermediary chemical species is due to the diverse composition of bio-oil. Being biomass-based, making it subject to composition changes, bio-oil is obtained via different processes, the two most common being fast pyrolysis and hydrothermal liquefaction. Different methods result in different bio-oil compositions even from the same original biomass. Understanding which biomass source and process results in a particular chemical makeup is of interest to those concerned with the refinement or direct application in chemical reactions of bio-oil. This paper presents a summary of published bio-oil production methods, origin biomass, and the resulting composition.
Zitieren
APA
Machado, H., Cristino, A. F., Orišková, S., & Santos, R. G. D. (2022). Bio-Oil: The Next-Generation Source of Chemicals. Reactions, 3(1), 118-137. https://doi.org/10.3390/reactions3010009
Vancouver
Machado H, Cristino AF, Orišková S, Santos RGD. Bio-Oil: The Next-Generation Source of Chemicals. Reactions. 2022;3(1):118-137. doi:10.3390/reactions3010009
BibTeX
@article{Machado2022,
author = {Machado, Henrique and Cristino, Ana F. and Orišková, Sofia and Santos, Rui Galhano dos},
title = {Bio-Oil: The Next-Generation Source of Chemicals},
journal = {Reactions},
year = {2022},
volume = {3},
number = {1},
pages = {118--137},
doi = {10.3390/reactions3010009}
}
EUVIMED